Some pharmacists worry that a U.S. executive order to lower drug prices could impact Taiwan. The order requires drugmakers to match their lowest global prices when selling to the U.S. There are concerns that companies might respond by raising prices in less profitable countries like Taiwan — or pulling out of those markets entirely.
